Logo image of CGC

CANOPY GROWTH CORP (CGC) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CGC - CA1380357048 - Common Stock

1.48 USD
-0.21 (-12.43%)
Last: 12/19/2025, 8:00:00 PM
1.48 USD
0 (0%)
After Hours: 12/19/2025, 8:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CGC. CGC was compared to 192 industry peers in the Pharmaceuticals industry. While CGC seems to be doing ok healthwise, there are quite some concerns on its profitability. CGC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CGC has reported negative net income.
In the past year CGC has reported a negative cash flow from operations.
In the past 5 years CGC always reported negative net income.
CGC had a negative operating cash flow in each of the past 5 years.
CGC Yearly Net Income VS EBIT VS OCF VS FCFCGC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1B -2B -3B

1.2 Ratios

The Return On Assets of CGC (-36.07%) is comparable to the rest of the industry.
CGC has a Return On Equity (-52.42%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -36.07%
ROE -52.42%
ROIC N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
CGC Yearly ROA, ROE, ROICCGC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

The Gross Margin of CGC (27.49%) is comparable to the rest of the industry.
The Profit Margin and Operating Margin are not available for CGC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CGC Yearly Profit, Operating, Gross MarginsCGC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

More info and screens

4

2. Health

2.1 Basic Checks

CGC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CGC has been increased compared to 1 year ago.
CGC has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CGC has been reduced compared to a year ago.
CGC Yearly Shares OutstandingCGC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
CGC Yearly Total Debt VS Total AssetsCGC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of -9.11, we must say that CGC is in the distress zone and has some risk of bankruptcy.
CGC has a worse Altman-Z score (-9.11) than 69.27% of its industry peers.
CGC has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
CGC has a Debt to Equity ratio of 0.33. This is comparable to the rest of the industry: CGC outperforms 41.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z -9.11
ROIC/WACCN/A
WACC11.41%
CGC Yearly LT Debt VS Equity VS FCFCGC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 5.50 indicates that CGC has no problem at all paying its short term obligations.
CGC has a better Current ratio (5.50) than 65.63% of its industry peers.
CGC has a Quick Ratio of 4.23. This indicates that CGC is financially healthy and has no problem in meeting its short term obligations.
CGC has a better Quick ratio (4.23) than 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 5.5
Quick Ratio 4.23
CGC Yearly Current Assets VS Current LiabilitesCGC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

3

3. Growth

3.1 Past

CGC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.25%, which is quite impressive.
The Revenue has decreased by -0.67% in the past year.
Measured over the past years, CGC shows a decrease in Revenue. The Revenue has been decreasing by -7.57% on average per year.
EPS 1Y (TTM)58.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.32%
Revenue 1Y (TTM)-0.67%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%5.86%

3.2 Future

CGC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.29% yearly.
CGC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.39% yearly.
EPS Next Y94.86%
EPS Next 2Y40.65%
EPS Next 3Y25.5%
EPS Next 5Y15.29%
Revenue Next Year2.14%
Revenue Next 2Y4.71%
Revenue Next 3Y4.75%
Revenue Next 5Y5.39%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CGC Yearly Revenue VS EstimatesCGC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
CGC Yearly EPS VS EstimatesCGC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -20 -40 -60

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CGC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CGC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CGC Price Earnings VS Forward Price EarningsCGC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CGC Per share dataCGC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

CGC's earnings are expected to grow with 25.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.65%
EPS Next 3Y25.5%

More info and screens

0

5. Dividend

5.1 Amount

CGC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

CANOPY GROWTH CORP

NASDAQ:CGC (12/19/2025, 8:00:00 PM)

After market: 1.48 0 (0%)

1.48

-0.21 (-12.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)02-05 2026-02-05/bmo
Inst Owners10.93%
Inst Owner Change91.21%
Ins Owners0.18%
Ins Owner Change5.67%
Market Cap545.32M
Revenue(TTM)278.61M
Net Income(TTM)-385.85M
Analysts47.69
Price Target2.72 (83.78%)
Short Float %10.18%
Short Ratio1.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)51.01%
Min EPS beat(2)8.22%
Max EPS beat(2)93.8%
EPS beat(4)2
Avg EPS beat(4)-51.44%
Min EPS beat(4)-206.63%
Max EPS beat(4)93.8%
EPS beat(8)2
Avg EPS beat(8)-152.68%
EPS beat(12)3
Avg EPS beat(12)-166.46%
EPS beat(16)4
Avg EPS beat(16)-163.73%
Revenue beat(2)1
Avg Revenue beat(2)0.9%
Min Revenue beat(2)-7.76%
Max Revenue beat(2)9.57%
Revenue beat(4)3
Avg Revenue beat(4)3.88%
Min Revenue beat(4)-7.76%
Max Revenue beat(4)9.57%
Revenue beat(8)5
Avg Revenue beat(8)2.85%
Revenue beat(12)6
Avg Revenue beat(12)1.1%
Revenue beat(16)8
Avg Revenue beat(16)-0.85%
PT rev (1m)1.57%
PT rev (3m)-0.51%
EPS NQ rev (1m)0%
EPS NQ rev (3m)70.39%
EPS NY rev (1m)54.94%
EPS NY rev (3m)58.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.94%
Revenue NY rev (1m)-5.7%
Revenue NY rev (3m)-5.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.7
P/FCF N/A
P/OCF N/A
P/B 1.02
P/tB 1.24
EV/EBITDA N/A
EPS(TTM)-2.04
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS0.55
BVpS1.45
TBVpS1.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -36.07%
ROE -52.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.49%
FCFM N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.94%
Cap/Sales 2.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.5
Quick Ratio 4.23
Altman-Z -9.11
F-Score5
WACC11.41%
ROIC/WACCN/A
Cap/Depr(3y)15.39%
Cap/Depr(5y)45.04%
Cap/Sales(3y)2.72%
Cap/Sales(5y)9.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.32%
EPS Next Y94.86%
EPS Next 2Y40.65%
EPS Next 3Y25.5%
EPS Next 5Y15.29%
Revenue 1Y (TTM)-0.67%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%5.86%
Revenue Next Year2.14%
Revenue Next 2Y4.71%
Revenue Next 3Y4.75%
Revenue Next 5Y5.39%
EBIT growth 1Y51.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year89.39%
EBIT Next 3Y31%
EBIT Next 5Y19.3%
FCF growth 1Y81.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.69%
OCF growth 3YN/A
OCF growth 5YN/A

CANOPY GROWTH CORP / CGC FAQ

Can you provide the ChartMill fundamental rating for CANOPY GROWTH CORP?

ChartMill assigns a fundamental rating of 2 / 10 to CGC.


Can you provide the valuation status for CANOPY GROWTH CORP?

ChartMill assigns a valuation rating of 1 / 10 to CANOPY GROWTH CORP (CGC). This can be considered as Overvalued.


How profitable is CANOPY GROWTH CORP (CGC) stock?

CANOPY GROWTH CORP (CGC) has a profitability rating of 1 / 10.


What is the financial health of CANOPY GROWTH CORP (CGC) stock?

The financial health rating of CANOPY GROWTH CORP (CGC) is 4 / 10.